These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6774658)

  • 1. [Assessment of biological and hormonal diagnostic criteria in acromegaly (author's transl)].
    Bodson A; Crabbé J
    Ann Endocrinol (Paris); 1980; 41(3):225-6. PubMed ID: 6774658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acromegaly with normal growth-hormone levels and pituitary histology. Case report.
    Feingold KR; Goldfine ID; Weinstein PR
    J Neurosurg; 1979 Apr; 50(4):503-7. PubMed ID: 106097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal reaction of GH to TRH and l-dopa stimulation in acromegaly].
    Haniu K; Taya T; Aida M; Yoshinaga K
    Horumon To Rinsho; 1976 Nov; 24(11):1145-50. PubMed ID: 827402
    [No Abstract]   [Full Text] [Related]  

  • 4. Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery.
    Schaison G; Couzinet B; Moatti N; Pertuiset B
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):541-9. PubMed ID: 6411389
    [No Abstract]   [Full Text] [Related]  

  • 5. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 6. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
    Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
    Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly.
    Gelato MC; Merriam GR; Vance ML; Goldman JA; Webb C; Evans WS; Rock J; Oldfield EH; Molitch ME; Rivier J
    J Clin Endocrinol Metab; 1985 Feb; 60(2):251-7. PubMed ID: 3917454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and biochemical findings of acromegaly patients (author's transl)].
    Barwich D
    Med Klin; 1975 Oct; 70(44):1780-3. PubMed ID: 1102896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
    Hoyte KM; Martin JB
    J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of hGH glucose suppression test in acromegaly (author's transl)].
    Deng JY
    Zhonghua Nei Ke Za Zhi; 1981 Aug; 20(8):467-70. PubMed ID: 7338080
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of thyreoliberin VUFB in the diagnosis of acromegaly (author's transl)].
    Felt V; Nedvídková J; Shameti H; Kasafírek E
    Cas Lek Cesk; 1979 Feb; 118(8):232-4. PubMed ID: 109212
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal evaluation of 27 patients with acromegaly].
    Villabona C; Novials A; Soler J; Morató J; Gómez JM; Navarro MA
    Med Clin (Barc); 1985 Feb; 84(6):219-22. PubMed ID: 3920452
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism.
    Irie M; Tsushima T
    J Clin Endocrinol Metab; 1972 Jul; 35(1):97-100. PubMed ID: 4624350
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Ferrari C; Travaglini P; Ambrosi B; Spada A
    J Clin Endocrinol Metab; 1973 Jun; 36(6):1259-62. PubMed ID: 4196265
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Travaglini P; Paracchi A; Spada A; Lewin A
    J Clin Endocrinol Metab; 1973 Aug; 37(2):338-40. PubMed ID: 4198260
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
    [No Abstract]   [Full Text] [Related]  

  • 18. Acromegaly in an infant.
    Blumberg DL; Sklar CA; David R; Rothenberg S; Bell J
    Pediatrics; 1989 Jun; 83(6):998-1002. PubMed ID: 2657629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.